Search form
Search
contact us
Navigation
home
boards
job center
job ratings
cp wire
device news
trending now
trending in pharma/biotech
trending in device
pharmagather
advertise
Legal Help
login/register
You are here
Home
»
companies
» Regeneron
Regeneron
Novartis sues Regeneron over manufacturing methods
Novartis sues Regeneron over manufacturing methods
Biopharma Dive
Novartis
Regeneron
drug manufacturing
Zaltrap
Eylea
Flag link:
Regeneron, Alnylam partner to turn discovery into new drugs for NASH
Regeneron, Alnylam partner to turn discovery into new drugs for NASH
Biopharma Dive
Regeneron
Alnylam
NASH
R&D
drug discovery
Flag link:
Regeneron’s Eylea Shows Promise in Late-Stage Diabetic Retinopathy Trial
Regeneron’s Eylea Shows Promise in Late-Stage Diabetic Retinopathy Trial
Xtalks
Regeneron
Eylea
diabetic retinopathy
Flag link:
With Novartis and Roche gunning to carve up Eylea franchise, Regeneron has another PhIII success story to tell
With Novartis and Roche gunning to carve up Eylea franchise, Regeneron has another PhIII success story to tell
Endpoints
Novartis
Roche
Eylea
Regeneron
Flag link:
Amgen faces tough one-two blow as competition mounts for Repatha and Sensipar
Amgen faces tough one-two blow as competition mounts for Repatha and Sensipar
Fierce Pharma
Amgen
Repatha
Sensipar
generics
Sanofi
Regeneron
Praluent
Flag link:
Regeneron/Sanofi heart drug succeeds in major trial; Will insurers pay?
Regeneron/Sanofi heart drug succeeds in major trial; Will insurers pay?
Yahoo/Reuters
Regeneron
Sanofi
Praluent
insurers
clinical trials
Flag link:
Regeneron to Slash Price of Cholesterol Drug After Showing it Saved Lives
Regeneron to Slash Price of Cholesterol Drug After Showing it Saved Lives
Xconomy
Regeneron
cholesterol
drug pricing
Sanofi
Praluent
Flag link:
Here's What Weighed on Regeneron Pharmaceuticals Inc. in February
Here's What Weighed on Regeneron Pharmaceuticals Inc. in February
Motley Fool
Regeneron
Eylea
Flag link:
Regeneron vision drug Eylea sees upward tick in unexplained side-effect cases
Regeneron vision drug Eylea sees upward tick in unexplained side-effect cases
Fierce Pharma
Regeneron
Eylea
side effects
Flag link:
The Moment Of Truth Is Coming For Struggling And Expensive Cholesterol Drugs
The Moment Of Truth Is Coming For Struggling And Expensive Cholesterol Drugs
Forbes
cholesterol
PCSK9 inhibitors
Sanofi
Regeneron
Praluent
Amgen
Repatha
Flag link:
Regeneron’s coming late to a group of drugs that’s already worth billions — here’s why the company thinks it can still compete
Regeneron’s coming late to a group of drugs that’s already worth billions — here’s why the company thinks it can still compete
SF Gate, CA
Regeneron
PDL-1 inhibitors
cemiplimab
Flag link:
Racing to replace opioids, biopharma is betting on pain drugs with a checkered past
Racing to replace opioids, biopharma is betting on pain drugs with a checkered past
Stat
opioids
painkillers
NGF inhibitors
Regeneron
Pfizer
Eli Lilly
NGF blockers
Flag link:
Sanofi and Regeneron's Dupixent launch is about to get a cash infusion
Sanofi and Regeneron's Dupixent launch is about to get a cash infusion
Fierce Pharma
Sanofi
Regeneron
Dupixent
drug launches
eczema
JPMHC 2018
Flag link:
JPM18: Regeneron, Sanofi boost I/O investment
JPM18: Regeneron, Sanofi boost I/O investment
Biopharma Dive
Regeneron
Sanofi
immuno-oncology
JPMHC 2018
Flag link:
Sanofi and Regeneron boost investment in cancer drug cemiplimab
Sanofi and Regeneron boost investment in cancer drug cemiplimab
Yahoo/Reuters
Sanofi
Regeneron
cemiplimab
cancer
dupilumab
Flag link:
Mylan, Momenta take aim at Regeneron’s Eylea with biosimilar
Mylan, Momenta take aim at Regeneron’s Eylea with biosimilar
Drug Delivery Business News
Mylan Labs
Momenta Pharmaceuticals
Regeneron
Eylea
biosimilars
diabetic macular edema
wet age-related macular degeneration
M710
Flag link:
On a new deal spree, Regeneron buys into ISA in pursuit of a checkpoint combo
On a new deal spree, Regeneron buys into ISA in pursuit of a checkpoint combo
Endpoints
Regeneron
ISA
cervical cancer
head and neck cancer
cemiplimab
Flag link:
Will This Drug Kick-Start Regeneron Pharmaceuticals Shares?
Will This Drug Kick-Start Regeneron Pharmaceuticals Shares?
Motley Fool
Regeneron
Sanofi
cemiplimab
skin cancer
Flag link:
Regeneron, Sanofi are ready to debut the 6th PD-1/L1. Is it still possible to stand out from the growing crowd?
Regeneron, Sanofi are ready to debut the 6th PD-1/L1. Is it still possible to stand out from the growing crowd?
Endpoints
Regeneron
Sanofi
anti-PD-L1
cemiplimab
advanced cutaneous squamous cell carcinoma
Flag link:
Regeneron CEO Schleifer, a year after public Pfizer spat, slams Allergan for tribal deal
Regeneron CEO Schleifer, a year after public Pfizer spat, slams Allergan for tribal deal
Fierce Pharma
Regeneron
Allergan
Pharma CEOs
Leonard Schleifer
Pfizer
patents
Restasis
Flag link:
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »